The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial
Population-based genomic screening is at the forefront of a new approach to disease prevention. Yet the lack of diversity in genome wide association studies and ongoing debates about the appropriate use of racial and ethnic categories in genomics raise key questions about the translation of genomic...
Saved in:
Main Authors: | Jennifer Elyse James, Leslie Riddle, Barbara Ann Koenig, Galen Joseph |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/64a70eed548c4deaad4dba9ea765bc09 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial.
by: Jennifer Elyse James, et al.
Published: (2021) -
Precision oncology- the future of personalized cancer medicine?
by: Ann M. Bode, et al.
Published: (2017) -
Personalized immunotherapy in cancer precision medicine
by: Kazuma Kiyotani, et al.
Published: (2021) -
SYNTHETIC BIOLOGY MEETS PRECISION MEDICINE: DRUG REPURPOSING FOR BLOOD CANCER PRECISION MEDICINE
by: Deepak Balaji Thimiri Govindaraj Thimiri Govindaraj
Published: (2021) -
Precision medicine: the foundation of future cancer therapeutics
by: Seung Ho Shin, et al.
Published: (2017)